25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Vistin Pharma ASA
Buy, Hold or Sell?

Let's analyze Vistin together

I guess you are interested in Vistin Pharma ASA. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Vistin Pharma ASA. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Vistin Pharma ASA

I send you an email if I find something interesting about Vistin Pharma ASA.

1. Quick Overview

1.1. Quick analysis of Vistin (30 sec.)










1.2. What can you expect buying and holding a share of Vistin? (30 sec.)

How much money do you get?

How much money do you get?
kr0.11
When do you have the money?
1 year
How often do you get paid?
55.0%

What is your share worth?

Current worth
kr6.63
Expected worth in 1 year
kr7.01
How sure are you?
80.0%

+ What do you gain per year?

Total Gains per Share
kr1.62
Return On Investment
6.8%

For what price can you sell your share?

Current Price per Share
kr24.00
Expected price per share
kr20.31 - kr28.26
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Vistin (5 min.)




Live pricePrice per Share (EOD)
kr24.00
Intrinsic Value Per Share
kr6.13 - kr7.50
Total Value Per Share
kr12.76 - kr14.13

2.2. Growth of Vistin (5 min.)




Is Vistin growing?

Current yearPrevious yearGrowGrow %
How rich?$26.5m$24.2m$3.1m11.5%

How much money is Vistin making?

Current yearPrevious yearGrowGrow %
Making money$1.5m$323k$1.2m79.0%
Net Profit Margin15.4%3.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Vistin (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Vistin?

Welcome investor! Vistin's management wants to use your money to grow the business. In return you get a share of Vistin.

First you should know what it really means to hold a share of Vistin. And how you can make/lose money.

Speculation

The Price per Share of Vistin is kr24.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Vistin.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Vistin, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr6.63. Based on the TTM, the Book Value Change Per Share is kr0.09 per quarter. Based on the YOY, the Book Value Change Per Share is kr0.09 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.31 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Vistin.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps0.040.2%0.030.1%0.010.0%0.010.0%0.010.0%
Usd Book Value Change Per Share-0.010.0%0.010.0%0.010.0%0.030.1%0.030.1%
Usd Dividend Per Share0.050.2%0.030.1%0.010.0%0.020.1%0.020.1%
Usd Total Gains Per Share0.040.2%0.040.2%0.020.1%0.050.2%0.050.2%
Usd Price Per Share2.02-2.08-1.54-1.60-1.60-
Price to Earnings Ratio12.96-17.76--10.71-59.04-59.04-
Price-to-Total Gains Ratio51.84-68.58-34.69-205.46-205.46-
Price to Book Ratio3.38-3.37-2.80-2.78-2.78-
Price-to-Total Gains Ratio51.84-68.58-34.69-205.46-205.46-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.1672
Number of shares461
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.030.02
Usd Book Value Change Per Share0.010.03
Usd Total Gains Per Share0.040.05
Gains per Quarter (461 shares)16.8922.02
Gains per Year (461 shares)67.5888.08
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1521658335578
21043112666110166
31564719499166254
420862262131221342
526078330164276430
631293398197331518
7364109466230387606
8416124534263442694
9468140602296497782
10520156670329552870

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%9.03.00.075.0%16.04.00.080.0%16.04.00.080.0%16.04.00.080.0%
Book Value Change Per Share2.02.00.050.0%7.05.00.058.3%12.08.00.060.0%12.08.00.060.0%12.08.00.060.0%
Dividend per Share2.00.02.050.0%6.00.06.050.0%11.00.09.055.0%11.00.09.055.0%11.00.09.055.0%
Total Gains per Share4.00.00.0100.0%10.02.00.083.3%16.04.00.080.0%16.04.00.080.0%16.04.00.080.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Vistin Pharma ASA compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.0680.093-172%0.094-172%0.332-120%0.332-120%
Book Value Per Share--6.6346.851-3%6.062+9%6.543+1%6.543+1%
Current Ratio--1.5661.938-19%1.451+8%3.075-49%3.075-49%
Debt To Asset Ratio--0.2700.237+14%0.301-10%0.228+18%0.228+18%
Debt To Equity Ratio--0.3700.313+18%0.432-14%0.312+18%0.312+18%
Dividend Per Share--0.5000.312+60%0.123+307%0.197+153%0.197+153%
Eps--0.4320.385+12%0.081+435%0.067+545%0.067+545%
Free Cash Flow Per Share--0.1560.117+33%0.230-32%-0.220+241%-0.220+241%
Free Cash Flow To Equity Per Share--0.1560.117+33%-0.017+111%-0.228+246%-0.228+246%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--7.496--------
Intrinsic Value_10Y_min--6.125--------
Intrinsic Value_1Y_max---0.117--------
Intrinsic Value_1Y_min---0.116--------
Intrinsic Value_3Y_max--0.309--------
Intrinsic Value_3Y_min--0.282--------
Intrinsic Value_5Y_max--1.534--------
Intrinsic Value_5Y_min--1.367--------
Market Cap1064270400.000+7%993319040.0001022143030.000-3%756075430.000+31%785786312.000+26%785786312.000+26%
Net Profit Margin--0.1810.154+17%0.036+401%-0.001+101%-0.001+101%
Operating Margin----0%0.094-100%-0.0320%-0.0320%
Operating Ratio--1.1281.327-15%1.544-27%1.405-20%1.405-20%
Pb Ratio3.618+7%3.3773.367+0%2.796+21%2.777+22%2.777+22%
Pe Ratio13.885+7%12.95917.758-27%-10.706+183%59.036-78%59.036-78%
Price Per Share24.000+7%22.40023.050-3%17.050+31%17.720+26%17.720+26%
Price To Free Cash Flow Ratio38.444+7%35.881-125.975+451%32.206+11%-35.954+200%-35.954+200%
Price To Total Gains Ratio55.541+7%51.83868.584-24%34.691+49%205.459-75%205.459-75%
Quick Ratio--0.6810.703-3%0.629+8%1.345-49%1.345-49%
Return On Assets--0.0480.043+11%0.008+462%0.011+322%0.011+322%
Return On Equity--0.0650.056+16%0.012+421%0.007+899%0.007+899%
Total Gains Per Share--0.4320.406+6%0.217+99%0.529-18%0.529-18%
Usd Book Value--26564002.50027433343.175-3%24275032.950+9%26201565.390+1%26201565.390+1%
Usd Book Value Change Per Share---0.0060.008-172%0.009-172%0.030-120%0.030-120%
Usd Book Value Per Share--0.5990.619-3%0.547+9%0.591+1%0.591+1%
Usd Dividend Per Share--0.0450.028+60%0.011+307%0.018+153%0.018+153%
Usd Eps--0.0390.035+12%0.007+435%0.006+545%0.006+545%
Usd Free Cash Flow--624966.300470214.675+33%920879.400-32%-879797.415+241%-879797.415+241%
Usd Free Cash Flow Per Share--0.0140.011+33%0.021-32%-0.020+241%-0.020+241%
Usd Free Cash Flow To Equity Per Share--0.0140.011+33%-0.002+111%-0.021+246%-0.021+246%
Usd Market Cap96103617.120+7%89696709.31292299515.609-3%68273611.329+31%70956503.974+26%70956503.974+26%
Usd Price Per Share2.167+7%2.0232.081-3%1.540+31%1.600+26%1.600+26%
Usd Profit--1730328.6001541804.775+12%323048.250+436%268583.805+544%268583.805+544%
Usd Revenue--9579114.3009880784.025-3%8875067.775+8%7174298.880+34%7174298.880+34%
Usd Total Gains Per Share--0.0390.037+6%0.020+99%0.048-18%0.048-18%
 EOD+4 -4MRQTTM+18 -16YOY+25 -105Y+22 -1210Y+22 -12

3.3 Fundamental Score

Let's check the fundamental score of Vistin Pharma ASA based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1513.885
Price to Book Ratio (EOD)Between0-13.618
Net Profit Margin (MRQ)Greater than00.181
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.681
Current Ratio (MRQ)Greater than11.566
Debt to Asset Ratio (MRQ)Less than10.270
Debt to Equity Ratio (MRQ)Less than10.370
Return on Equity (MRQ)Greater than0.150.065
Return on Assets (MRQ)Greater than0.050.048
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Vistin Pharma ASA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5033.784
Ma 20Greater thanMa 5025.890
Ma 50Greater thanMa 10026.226
Ma 100Greater thanMa 20023.900
OpenGreater thanClose24.200
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Vistin Pharma ASA

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. Vistin Pharma ASA was founded in 1969 and is headquartered in Oslo, Norway.

Fundamental data was last updated by Penke on 2024-11-03 13:23:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Vistin earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Vistin to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 18.1% means that kr0.18 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Vistin Pharma ASA:

  • The MRQ is 18.1%. The company is making a huge profit. +2
  • The TTM is 15.4%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ18.1%TTM15.4%+2.6%
TTM15.4%YOY3.6%+11.8%
TTM15.4%5Y-0.1%+15.6%
5Y-0.1%10Y-0.1%0.0%
4.3.1.2. Return on Assets

Shows how efficient Vistin is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Vistin to the Drug Manufacturers - Specialty & Generic industry mean.
  • 4.8% Return on Assets means that Vistin generated kr0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Vistin Pharma ASA:

  • The MRQ is 4.8%. Using its assets, the company is less efficient in making profit.
  • The TTM is 4.3%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.8%TTM4.3%+0.5%
TTM4.3%YOY0.8%+3.5%
TTM4.3%5Y1.1%+3.2%
5Y1.1%10Y1.1%0.0%
4.3.1.3. Return on Equity

Shows how efficient Vistin is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Vistin to the Drug Manufacturers - Specialty & Generic industry mean.
  • 6.5% Return on Equity means Vistin generated kr0.07 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Vistin Pharma ASA:

  • The MRQ is 6.5%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 5.6%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ6.5%TTM5.6%+0.9%
TTM5.6%YOY1.2%+4.4%
TTM5.6%5Y0.7%+5.0%
5Y0.7%10Y0.7%0.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Vistin Pharma ASA.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Vistin is operating .

  • Measures how much profit Vistin makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Vistin to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated kr0.00  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Vistin Pharma ASA:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY9.4%-9.4%
TTM-5Y-3.2%+3.2%
5Y-3.2%10Y-3.2%0.0%
4.3.2.2. Operating Ratio

Measures how efficient Vistin is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.13 means that the operating costs are kr1.13 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Vistin Pharma ASA:

  • The MRQ is 1.128. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.327. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.128TTM1.327-0.199
TTM1.327YOY1.544-0.217
TTM1.3275Y1.405-0.078
5Y1.40510Y1.4050.000
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Vistin Pharma ASA.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Vistin is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.57 means the company has kr1.57 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Vistin Pharma ASA:

  • The MRQ is 1.566. The company is able to pay all its short-term debts. +1
  • The TTM is 1.938. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.566TTM1.938-0.372
TTM1.938YOY1.451+0.487
TTM1.9385Y3.075-1.137
5Y3.07510Y3.0750.000
4.4.3.2. Quick Ratio

Measures if Vistin is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Vistin to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.68 means the company can pay off kr0.68 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Vistin Pharma ASA:

  • The MRQ is 0.681. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.703. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.681TTM0.703-0.021
TTM0.703YOY0.629+0.074
TTM0.7035Y1.345-0.642
5Y1.34510Y1.3450.000
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Vistin Pharma ASA.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Vistin assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Vistin to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.27 means that Vistin assets are financed with 27.0% credit (debt) and the remaining percentage (100% - 27.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Vistin Pharma ASA:

  • The MRQ is 0.270. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.237. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.270TTM0.237+0.033
TTM0.237YOY0.301-0.064
TTM0.2375Y0.228+0.009
5Y0.22810Y0.2280.000
4.5.4.2. Debt to Equity Ratio

Measures if Vistin is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Vistin to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 37.0% means that company has kr0.37 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Vistin Pharma ASA:

  • The MRQ is 0.370. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.313. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.370TTM0.313+0.057
TTM0.313YOY0.432-0.119
TTM0.3135Y0.312+0.000
5Y0.31210Y0.3120.000
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Vistin generates.

  • Above 15 is considered overpriced but always compare Vistin to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 12.96 means the investor is paying kr12.96 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Vistin Pharma ASA:

  • The EOD is 13.885. Based on the earnings, the company is underpriced. +1
  • The MRQ is 12.959. Based on the earnings, the company is underpriced. +1
  • The TTM is 17.758. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD13.885MRQ12.959+0.926
MRQ12.959TTM17.758-4.799
TTM17.758YOY-10.706+28.464
TTM17.7585Y59.036-41.278
5Y59.03610Y59.0360.000
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Vistin Pharma ASA:

  • The EOD is 38.444. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 35.881. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is -125.975. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD38.444MRQ35.881+2.563
MRQ35.881TTM-125.975+161.855
TTM-125.975YOY32.206-158.180
TTM-125.9755Y-35.954-90.020
5Y-35.95410Y-35.9540.000
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Vistin is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Vistin Pharma ASA:

  • The EOD is 3.618. Based on the equity, the company is fair priced.
  • The MRQ is 3.377. Based on the equity, the company is fair priced.
  • The TTM is 3.367. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.618MRQ3.377+0.241
MRQ3.377TTM3.367+0.009
TTM3.367YOY2.796+0.571
TTM3.3675Y2.777+0.590
5Y2.77710Y2.7770.000
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in NOK. All numbers in thousands.

Summary
Total Assets402,970
Total Liabilities108,795
Total Stockholder Equity294,175
 As reported
Total Liabilities 108,795
Total Stockholder Equity+ 294,175
Total Assets = 402,970

Assets

Total Assets402,970
Total Current Assets154,490
Long-term Assets248,480
Total Current Assets
Cash And Cash Equivalents 11,389
Net Receivables 67,216
Inventory 68,787
Total Current Assets  (as reported)154,490
Total Current Assets  (calculated)147,392
+/- 7,098
Long-term Assets
Property Plant Equipment 229,973
Long-term Assets  (as reported)248,480
Long-term Assets  (calculated)229,973
+/- 18,507

Liabilities & Shareholders' Equity

Total Current Liabilities98,658
Long-term Liabilities10,137
Total Stockholder Equity294,175
Total Current Liabilities
Short Long Term Debt 45,835
Accounts payable 13,443
Other Current Liabilities 39,380
Total Current Liabilities  (as reported)98,658
Total Current Liabilities  (calculated)98,658
+/-0
Long-term Liabilities
Long-term Liabilities Other 1,765
Long-term Liabilities  (as reported)10,137
Long-term Liabilities  (calculated)1,765
+/- 8,372
Total Stockholder Equity
Retained Earnings 98,360
Total Stockholder Equity (as reported)294,175
Total Stockholder Equity (calculated)98,360
+/- 195,815
Other
Capital Stock44,345
Common Stock Shares Outstanding 44,345
Net Debt 34,446
Net Invested Capital 340,010
Net Working Capital 55,832



6.2. Balance Sheets Structured

Currency in NOK. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-30
> Total Assets 
493,435
504,165
530,257
310,425
316,179
321,915
326,475
320,026
316,656
333,147
316,467
370,670
362,707
407,213
386,733
383,103
386,539
403,396
400,384
402,970
402,970400,384403,396386,539383,103386,733407,213362,707370,670316,467333,147316,656320,026326,475321,915316,179310,425530,257504,165493,435
   > Total Current Assets 
392,611
394,629
384,326
174,454
164,528
141,526
146,133
129,037
123,968
137,831
99,993
144,248
133,363
154,113
140,815
137,229
149,117
168,774
149,866
154,490
154,490149,866168,774149,117137,229140,815154,113133,363144,24899,993137,831123,968129,037146,133141,526164,528174,454384,326394,629392,611
       Cash And Cash Equivalents 
206,856
319,672
96,770
109,027
97,543
77,036
85,010
59,939
52,072
35,746
12,184
4,256
3,816
1,435
3,063
2,920
2,416
26,204
11,403
11,389
11,38911,40326,2042,4162,9203,0631,4353,8164,25612,18435,74652,07259,93985,01077,03697,543109,02796,770319,672206,856
       Net Receivables 
44,896
48,931
43,036
36,388
39,015
31,854
34,567
40,767
44,712
43,091
42,238
77,089
61,704
69,232
56,488
53,729
55,319
47,023
61,082
67,216
67,21661,08247,02355,31953,72956,48869,23261,70477,08942,23843,09144,71240,76734,56731,85439,01536,38843,03648,93144,896
       Inventory 
27,689
24,107
24,498
29,038
27,970
31,788
26,555
28,330
27,184
42,907
45,571
62,903
67,844
83,446
81,263
80,579
85,088
80,171
70,707
68,787
68,78770,70780,17185,08880,57981,26383,44667,84462,90345,57142,90727,18428,33026,55531,78827,97029,03824,49824,10727,689
   > Long-term Assets 
100,825
109,535
145,931
135,971
151,651
180,389
180,343
190,989
192,687
195,316
216,474
226,422
229,344
248,031
245,918
245,873
237,423
234,622
250,518
248,480
248,480250,518234,622237,423245,873245,918248,031229,344226,422216,474195,316192,687190,989180,343180,389151,651135,971145,931109,535100,825
       Property Plant Equipment 
0
101,802
101,288
100,968
117,924
145,261
147,720
160,642
162,607
167,457
184,342
194,358
195,389
219,430
216,648
218,433
216,608
219,984
226,607
229,973
229,973226,607219,984216,608218,433216,648219,430195,389194,358184,342167,457162,607160,642147,720145,261117,924100,968101,288101,8020
       Other Assets 
0
7,734
44,643
35,003
33,727
35,128
32,622
30,347
30,080
27,859
32,132
32,064
33,955
28,535
29,270
27,441
0
0
0
0
000027,44129,27028,53533,95532,06432,13227,85930,08030,34732,62235,12833,72735,00344,6437,7340
> Total Liabilities 
85,312
90,769
247,673
51,471
52,695
49,510
45,283
52,940
48,532
57,260
55,850
109,811
108,551
133,950
116,448
105,501
85,444
80,626
103,215
108,795
108,795103,21580,62685,444105,501116,448133,950108,551109,81155,85057,26048,53252,94045,28349,51052,69551,471247,67390,76985,312
   > Total Current Liabilities 
62,647
73,238
230,020
34,223
34,109
32,204
27,813
35,393
31,091
41,035
39,654
93,846
89,106
111,671
100,528
89,814
69,660
69,473
92,732
98,658
98,65892,73269,47369,66089,814100,528111,67189,10693,84639,65441,03531,09135,39327,81332,20434,10934,223230,02073,23862,647
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
39,384
41,614
0
0
0
0
0
0
0
000000041,61439,38400000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
39,384
42,114
45,141
23,384
0
0
0
30,613
45,835
45,83530,61300023,38445,14142,11439,38400000000000
       Accounts payable 
26,579
23,612
17,074
14,808
21,306
17,893
14,078
24,849
19,377
20,808
22,957
42,866
30,411
41,428
20,671
33,940
47,931
18,916
16,665
13,443
13,44316,66518,91647,93133,94020,67141,42830,41142,86622,95720,80819,37724,84914,07817,89321,30614,80817,07423,61226,579
       Other Current Liabilities 
37,266
38,082
212,059
33,262
34,109
2,622
12,476
9,961
11,024
2,775
15,962
10,929
16,581
24,978
55,494
54,963
21,729
50,557
45,454
39,380
39,38045,45450,55721,72954,96355,49424,97816,58110,92915,9622,77511,0249,96112,4762,62234,10933,262212,05938,08237,266
   > Long-term Liabilities 
22,665
17,531
17,653
17,248
18,586
17,306
17,470
17,547
17,441
16,344
16,196
15,965
19,445
16,155
15,920
15,687
15,784
11,153
10,483
10,137
10,13710,48311,15315,78415,68715,92016,15519,44515,96516,19616,34417,44117,54717,47017,30618,58617,24817,65317,53122,665
       Long term Debt Total 
0
0
0
0
0
0
0
1,217
0
0
0
0
0
0
0
0
0
0
0
0
0000000000001,2170000000
       Capital Lease Obligations Min Short Term Debt
2,878
1,222
2,231
939
0
0
0
0
0
0
365
-39,251
-38,000
2,956
2,721
0
0
2,287
0
0
002,287002,7212,956-38,000-39,2513650000009392,2311,2222,878
       Long-term Liabilities Other 
20,066
0
16,309
939
2,277
976
1,140
1,217
16,331
513
365
134
3,614
-1
0
2,488
2,585
2
2,004
1,765
1,7652,00422,5852,4880-13,61413436551316,3311,2171,1409762,27793916,309020,066
> Total Stockholder Equity
408,123
413,396
282,584
258,954
263,484
272,405
281,192
267,086
268,124
275,887
260,617
260,859
254,156
273,263
270,285
277,602
301,095
322,770
297,169
294,175
294,175297,169322,770301,095277,602270,285273,263254,156260,859260,617275,887268,124267,086281,192272,405263,484258,954282,584413,396408,123
   Common Stock
0
44,345
44,345
44,345
44,345
44,345
44,345
44,308
44,345
44,345
44,345
44,345
44,345
44,345
44,345
44,345
0
0
0
0
000044,34544,34544,34544,34544,34544,34544,34544,34544,30844,34544,34544,34544,34544,34544,3450
   Retained Earnings 
90,377
95,649
-35,162
-14,448
-9,918
-996
7,791
15,894
16,894
24,538
9,387
9,629
2,926
22,140
19,055
26,372
49,865
71,540
79,197
98,360
98,36079,19771,54049,86526,37219,05522,1402,9269,6299,38724,53816,89415,8947,791-996-9,918-14,448-35,16295,64990,377
   Capital Surplus 
0
0
0
0
0
229,056
229,056
206,885
206,885
206,885
206,885
206,885
206,885
0
0
0
0
0
0
0
0000000206,885206,885206,885206,885206,885206,885229,056229,05600000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 
0
1
0
1
1
0
0
-1
0
0
0
0
0
0
0
0
0
0
0
0
000000000000-10011010



6.3. Balance Sheets

Currency in NOK. All numbers in thousands.




6.4. Cash Flows

Currency in NOK. All numbers in thousands.




6.5. Income Statements

Currency in NOK. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in NOK. All numbers in thousands.

Gross Profit (+$)
totalRevenue435,391
Cost of Revenue-233,150
Gross Profit259,685202,241
 
Operating Income (+$)
Gross Profit259,685
Operating Expense-366,794
Operating Income68,597-107,109
 
Operating Expense (+$)
Research Development0
Selling General Administrative26,099
Selling And Marketing Expenses0
Operating Expense366,79426,099
 
Net Interest Income (+$)
Interest Income220
Interest Expense-2,266
Other Finance Cost-111
Net Interest Income-2,157
 
Pretax Income (+$)
Operating Income68,597
Net Interest Income-2,157
Other Non-Operating Income Expenses0
Income Before Tax (EBT)58,51868,597
EBIT - interestExpense = -2,266
45,596
47,862
Interest Expense2,266
Earnings Before Interest and Taxes (EBIT)060,784
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax58,518
Tax Provision-12,923
Net Income From Continuing Ops45,59545,595
Net Income45,596
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net02,157
 

Technical Analysis of Vistin
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Vistin. The general trend of Vistin is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Vistin's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Vistin Pharma ASA.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 27.47 < 28.26.

The bearish price targets are: 22.67 > 22.47 > 20.31.

Tweet this
Vistin Pharma ASA Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Vistin Pharma ASA. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Vistin Pharma ASA Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Vistin Pharma ASA. The current macd is -0.5133639.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Vistin price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Vistin. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Vistin price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Vistin Pharma ASA Daily Moving Average Convergence/Divergence (MACD) ChartVistin Pharma ASA Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Vistin Pharma ASA. The current adx is 25.81.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Vistin shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Vistin Pharma ASA Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Vistin Pharma ASA. The current sar is 26.27.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Vistin Pharma ASA Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Vistin Pharma ASA. The current rsi is 33.78. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Vistin Pharma ASA Daily Relative Strength Index (RSI) ChartVistin Pharma ASA Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Vistin Pharma ASA. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Vistin price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Vistin Pharma ASA Daily Stochastic Oscillator ChartVistin Pharma ASA Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Vistin Pharma ASA. The current cci is -147.66733195.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Vistin Pharma ASA Daily Commodity Channel Index (CCI) ChartVistin Pharma ASA Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Vistin Pharma ASA. The current cmo is -45.48756674.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Vistin Pharma ASA Daily Chande Momentum Oscillator (CMO) ChartVistin Pharma ASA Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Vistin Pharma ASA. The current willr is -93.51685002.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Vistin Pharma ASA Daily Williams %R ChartVistin Pharma ASA Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Vistin Pharma ASA.

Vistin Pharma ASA Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Vistin Pharma ASA. The current atr is 0.91238511.

Vistin Pharma ASA Daily Average True Range (ATR) ChartVistin Pharma ASA Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Vistin Pharma ASA. The current obv is 1,932,437.

Vistin Pharma ASA Daily On-Balance Volume (OBV) ChartVistin Pharma ASA Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Vistin Pharma ASA. The current mfi is 31.91.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Vistin Pharma ASA Daily Money Flow Index (MFI) ChartVistin Pharma ASA Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Vistin Pharma ASA.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-07-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-08STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-09WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-30STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-31STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-20MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-21STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-23WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-26RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-09-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-10STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-13STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-09-17WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-24RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-09-25STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-08MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-10-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-18STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-10-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-10-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.

6.3. Candlestick Patterns

Vistin Pharma ASA Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Vistin Pharma ASA based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5033.784
Ma 20Greater thanMa 5025.890
Ma 50Greater thanMa 10026.226
Ma 100Greater thanMa 20023.900
OpenGreater thanClose24.200
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Vistin with someone you think should read this too:
  • Are you bullish or bearish on Vistin? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Vistin? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Vistin Pharma ASA

I send you an email if I find something interesting about Vistin Pharma ASA.


Comments

How you think about this?

Leave a comment

Stay informed about Vistin Pharma ASA.

Receive notifications about Vistin Pharma ASA in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.